{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:24:45Z","timestamp":1791339885752,"version":"4.3.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2024-00334857"],"award-info":[{"award-number":["RS-2024-00334857"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HI21C1389"],"award-info":[{"award-number":["HI21C1389"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jtha.2026.01.018","type":"journal-article","created":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T16:13:20Z","timestamp":1770999200000},"page":"1747-1758","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development of dynamic prediction models for venous thromboembolism recurrence and bleeding risks to guide personalized anticoagulant therapy"],"prefix":"10.1016","volume":"24","author":[{"given":"Jonghyun","family":"Jeong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Mi","family":"Ah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Min","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangil","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaekyu","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyu-Nam","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2261-7330","authenticated-orcid":false,"given":"Ju-Yeun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.01.018_bib1","doi-asserted-by":"crossref","first-page":"e254","DOI":"10.1161\/CIR.0000000000000950","article-title":"Heart Disease and Stroke Statistics\u20142021 update: a report from the American Heart Association","volume":"143","author":"Virani","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2026.01.018_bib2","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41569-022-00787-6","article-title":"Epidemiology and prevention of venous thromboembolism","volume":"20","author":"Lutsey","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jtha.2026.01.018_bib3","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4250\/jcvi.2021.0014","volume":"29","author":"Kim","year":"2021","journal-title":"J Cardiovasc Imaging"},{"key":"10.1016\/j.jtha.2026.01.018_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.thromres.2020.05.036","article-title":"Adherence to and persistence with direct oral anticoagulant therapy among patients with new onset venous thromboembolism receiving extended anticoagulant therapy and followed by a centralized anticoagulation service","volume":"193","author":"Packard","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2026.01.018_bib5","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2026.01.018_bib6","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1182\/blood-2013-12-512681","article-title":"Duration of anticoagulant therapy for deep vein thrombosis and pulmonary embolism","volume":"123","author":"Kearon","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.01.018_bib7","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1182\/blood-2014-01-548065","article-title":"D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study","volume":"124","author":"Palareti","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.01.018_bib8","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1016\/j.chest.2021.07.055","article-title":"Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report","volume":"160","author":"Stevens","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2026.01.018_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/jth.12234","article-title":"Optimal treatment duration of venous thrombosis","volume":"11","author":"Ageno","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.018_bib10","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa1113697","article-title":"Extended use of dabigatran, warfarin, or placebo in venous thromboembolism","volume":"368","author":"Schulman","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.01.018_bib11","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"Bauersachs","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.01.018_bib12","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1207541","article-title":"Apixaban for extended treatment of venous thromboembolism","volume":"368","author":"Agnelli","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.01.018_bib13","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/eurheartj\/ehac776","article-title":"VTE-PREDICT study group. Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score","volume":"44","author":"de Winter","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2026.01.018_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/eurheartj\/ehad618","article-title":"The Vienna Prediction Model for identifying patients at low risk of recurrent venous thromboembolism: a prospective cohort study","volume":"45","author":"Kyrle","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2026.01.018_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002883","article-title":"Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: the Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP)","volume":"16","author":"Timp","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/j.jtha.2026.01.018_bib16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejim.2015.12.010","article-title":"A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (DAMOVES)","volume":"29","author":"Franco Moreno","year":"2016","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jtha.2026.01.018_bib17","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1538-7836.2012.04735.x","article-title":"Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)","volume":"10","author":"Tosetto","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.01.018_bib18","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1183\/13993003.00280-2016","article-title":"Prediction of bleeding events in patients with venous thromboembolism on stable anticoagulation treatment","volume":"48","author":"Klok","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jtha.2026.01.018_bib19","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/archinte.160.6.761","article-title":"Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study","volume":"160","author":"Heit","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jtha.2026.01.018_bib20","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1001\/jama.293.19.2352","article-title":"Thrombophilia, clinical factors, and recurrent venous thrombotic events","volume":"293","author":"Christiansen","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2026.01.018_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1399955","article-title":"Exploring bleeding in oral anticoagulant users: assessing incidence by indications and risk factors in the entire nationwide cohort","volume":"15","author":"Jeong","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jtha.2026.01.018_bib22","doi-asserted-by":"crossref","first-page":"718","DOI":"10.3346\/jkms.2017.32.5.718","article-title":"Towards actualizing the value potential of Korea Health Insurance Review and Assessment (HIRA) data as a resource for health research: strengths, limitations, applications, and strategies for optimal use of HIRA data","volume":"32","author":"Kim","year":"2017","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jtha.2026.01.018_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2026.01.018_bib24","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/sim.7992","article-title":"Minimum sample size for developing a multivariable prediction model: PART II - binary and time-to-event outcomes","volume":"38","author":"Riley","year":"2019","journal-title":"Stat Med"},{"key":"10.1016\/j.jtha.2026.01.018_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta20120","volume":"20","author":"Ensor","year":"2016","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jtha.2026.01.018_bib26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.14345\/ceth.21003","article-title":"Recurrence of cancer-associated venous thromboembolism between 2009 and 2013: a nationwide Korean study","volume":"7","author":"Hwang","year":"2021","journal-title":"Clin Exp Thromb Hemost"},{"key":"10.1016\/j.jtha.2026.01.018_bib27","doi-asserted-by":"crossref","first-page":"20","DOI":"10.7326\/M21-0717","article-title":"Risk for recurrent venous thromboembolism and bleeding with apixaban compared with rivaroxaban: an analysis of real-world data","volume":"175","author":"Dawwas","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2026.01.018_bib28","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012078","article-title":"Safety and effectiveness of contemporary P2Y12 inhibitors in an East Asian population with acute coronary syndrome: a nationwide population-based cohort study","volume":"8","author":"Yun","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jtha.2026.01.018_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmedinf.2024.105565","article-title":"Evaluating the effectiveness of a sliding window technique in machine learning models for mortality prediction in ICU cardiac arrest patients","volume":"191","author":"Danay","year":"2024","journal-title":"Int J Med Inform"},{"key":"10.1016\/j.jtha.2026.01.018_bib30","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nrcardio.2015.83","article-title":"Epidemiology of venous thromboembolism","volume":"12","author":"Heit","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jtha.2026.01.018_bib31","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11239-020-02319-w","article-title":"Bleeding risk in patients with venous thromboembolic events treated with new oral anticoagulants","volume":"52","author":"Wallvik","year":"2021","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2026.01.018_bib32","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1097\/MBC.0000000000001140","article-title":"Risk factors for recurrent venous thromboembolism: a real-world analysis","volume":"33","author":"Fu","year":"2022","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jtha.2026.01.018_bib33","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/1536867X211025836","article-title":"Bootstrap internal validation command for predictive logistic regression models","volume":"21","author":"Fernandez-Felix","year":"2021","journal-title":"Stata J"},{"key":"10.1016\/j.jtha.2026.01.018_bib34","series-title":"Advances in large margin classifiers","first-page":"61","article-title":"Probabilistic outputs for support vector machines and comparisons to regularized likelihood methods","author":"Platt","year":"2000"},{"key":"10.1016\/j.jtha.2026.01.018_bib35","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000507276","article-title":"Assessing the predictive performance of probabilistic caries risk assessment models: the importance of calibration","volume":"54","author":"Trottini","year":"2020","journal-title":"Caries Res"},{"key":"10.1016\/j.jtha.2026.01.018_bib36","first-page":"249","article-title":"Clinical implication of megestrol acetate in metastatic gastric cancer: a big data analysis from Health Insurance Review and Assessment (HIRA) database","volume":"32","author":"Lee","year":"2024","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jtha.2026.01.018_bib37","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jamda.2009.11.006","article-title":"Thrombotic risk and immobility in residents of long-term care facilities","volume":"11","author":"Zarowitz","year":"2010","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jtha.2026.01.018_bib38","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12933-022-01610-9","article-title":"Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy","volume":"21","author":"Pan","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jtha.2026.01.018_bib39","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/archinte.161.11.1405","article-title":"Use of statins and the subsequent development of deep vein thrombosis","volume":"161","author":"Ray","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jtha.2026.01.018_bib40","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1056\/NEJMoa0900241","article-title":"A randomized trial of rosuvastatin in the prevention of venous thromboembolism","volume":"360","author":"Glynn","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2026.01.018_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2023.100555","article-title":"Venous thromboembolism in patients with atrial fibrillation: a systematic review and meta-analysis of 4,170,027 patients","volume":"2","author":"Pastori","year":"2023","journal-title":"JACC Adv"},{"key":"10.1016\/j.jtha.2026.01.018_bib42","article-title":"Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis","volume":"366","author":"Khan","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2026.01.018_bib43","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1161\/CIRCULATIONAHA.109.925214","article-title":"Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model","volume":"121","author":"Eichinger","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2026.01.018_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/bimj.202200302","article-title":"Stability of clinical prediction models developed using statistical or machine learning methods","volume":"65","author":"Riley","year":"2023","journal-title":"Biom J"},{"key":"10.1016\/j.jtha.2026.01.018_bib45","article-title":"Importance of sample size on the quality and utility of AI-based prediction models for healthcare","volume":"7","author":"Riley","year":"2025","journal-title":"Lancet Digit Health"},{"key":"10.1016\/j.jtha.2026.01.018_bib46","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1055\/a-1690-8728","article-title":"Long-term risk of major bleeding after discontinuing anticoagulation for unprovoked venous thromboembolism: a systematic review and meta-analysis","volume":"122","author":"Khan","year":"2022","journal-title":"Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626001029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626001029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T19:58:32Z","timestamp":1783972712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626001029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1538783626001029"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.01.018","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of dynamic prediction models for venous thromboembolism recurrence and bleeding risks to guide personalized anticoagulant therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.01.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}